HK1171364A1 - 高孔隙度的速崩固體劑型及其包括生產粉末和凍干步驟的製備方法 - Google Patents

高孔隙度的速崩固體劑型及其包括生產粉末和凍干步驟的製備方法

Info

Publication number
HK1171364A1
HK1171364A1 HK12112331.9A HK12112331A HK1171364A1 HK 1171364 A1 HK1171364 A1 HK 1171364A1 HK 12112331 A HK12112331 A HK 12112331A HK 1171364 A1 HK1171364 A1 HK 1171364A1
Authority
HK
Hong Kong
Prior art keywords
dosage forms
solid dosage
powder
fast
way
Prior art date
Application number
HK12112331.9A
Other languages
English (en)
Inventor
Heinz Bauer Kurt
Original Assignee
Pantec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1171364(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pantec Ag filed Critical Pantec Ag
Publication of HK1171364A1 publication Critical patent/HK1171364A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK12112331.9A 2004-10-28 2012-11-29 高孔隙度的速崩固體劑型及其包括生產粉末和凍干步驟的製備方法 HK1171364A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04105381 2004-10-28

Publications (1)

Publication Number Publication Date
HK1171364A1 true HK1171364A1 (zh) 2013-03-28

Family

ID=34929781

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112331.9A HK1171364A1 (zh) 2004-10-28 2012-11-29 高孔隙度的速崩固體劑型及其包括生產粉末和凍干步驟的製備方法

Country Status (18)

Country Link
US (1) US8802145B2 (zh)
EP (1) EP1804764B1 (zh)
JP (1) JP4980228B2 (zh)
KR (1) KR101379297B1 (zh)
CN (2) CN102631289B (zh)
AT (1) ATE398444T1 (zh)
BR (1) BRPI0517256B8 (zh)
CA (1) CA2585426C (zh)
CY (1) CY1108343T1 (zh)
DE (1) DE602005007624D1 (zh)
DK (1) DK1804764T3 (zh)
ES (1) ES2308566T3 (zh)
HK (1) HK1171364A1 (zh)
IL (1) IL182745A (zh)
PL (1) PL1804764T3 (zh)
PT (1) PT1804764E (zh)
SI (1) SI1804764T1 (zh)
WO (1) WO2006045830A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
CN106666722B (zh) * 2017-03-13 2019-03-22 广州正广生物科技有限公司 一种螺旋藻片及其制备方法
ES2930199T3 (es) 2018-10-15 2022-12-07 Aprecia Pharmaceuticals LLC Método y sistema para formar una forma farmacéutica dentro de un envase
CN113490486A (zh) 2019-02-22 2021-10-08 康特伦英国斯温顿捷迪斯有限公司 最小化团聚、曝气和保持包含布洛芬的药物组合物的包衣
CA3129383A1 (en) * 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
CA3129404A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
EP3927314B1 (en) 2019-02-22 2023-08-23 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2024150261A1 (en) * 2023-01-10 2024-07-18 Zarqa University An oral pharmaceutical formulation and a method of preparation thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
EP0084705B1 (en) * 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Process for preparing solid shaped articles
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
PT914818E (pt) * 1996-06-14 2005-08-31 Kyowa Hakko Kogyo Kk Comprimido de desintegracao rapida por via intraoral
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
EP1202716A1 (en) * 1999-08-17 2002-05-08 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
EP1166655A1 (en) * 2000-06-19 2002-01-02 Société des Produits Nestlé S.A. A shelf-stable or chilled foam product and a process for its preparation
CN1290525A (zh) * 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
CN1197556C (zh) * 2003-02-12 2005-04-20 刘智 一种防治放疗、化疗呕吐的口腔快速崩解片剂及制备方法
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof

Also Published As

Publication number Publication date
JP4980228B2 (ja) 2012-07-18
US20090062241A1 (en) 2009-03-05
IL182745A (en) 2010-06-30
WO2006045830A1 (en) 2006-05-04
PL1804764T3 (pl) 2008-11-28
EP1804764A1 (en) 2007-07-11
DE602005007624D1 (de) 2008-07-31
KR20070069179A (ko) 2007-07-02
CN102631289A (zh) 2012-08-15
CN102631289B (zh) 2016-05-04
CA2585426C (en) 2013-05-14
BRPI0517256A (pt) 2008-10-07
ATE398444T1 (de) 2008-07-15
CY1108343T1 (el) 2014-02-12
EP1804764B1 (en) 2008-06-18
ES2308566T3 (es) 2008-12-01
DK1804764T3 (da) 2008-09-29
BRPI0517256B8 (pt) 2021-05-25
JP2008517979A (ja) 2008-05-29
PT1804764E (pt) 2008-09-11
CA2585426A1 (en) 2006-05-04
US8802145B2 (en) 2014-08-12
CN101065105A (zh) 2007-10-31
SI1804764T1 (sl) 2008-10-31
KR101379297B1 (ko) 2014-04-10
BRPI0517256B1 (pt) 2018-11-21
IL182745A0 (en) 2007-07-24

Similar Documents

Publication Publication Date Title
HK1171364A1 (zh) 高孔隙度的速崩固體劑型及其包括生產粉末和凍干步驟的製備方法
WO2018140676A3 (en) Compositions in the form of dissolvable solid structures
WO2014059252A3 (en) Personal care composition in the form of a dissolvable article
WO2007046005A3 (en) A reconstituted tobacco with bonded flavorant, smoking article and methods
WO2007058923A3 (en) Composition of fentanyl citrate oral solid transmucosal dosage form, dextrose monohydrate as major excipient and binding material therefor and methods of producing them
AR055561A1 (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
EP2666457A3 (en) Process for forming a non-lathering personal care article in the form of a dissolvable solid foam
IL173885A (en) Ethyl – 3– [(2– {4– (hexyloxycarbonylamino – imino – methyl) –phenylamino] –methyl} –1 – methyl – H1– benzimidazole-5-carbonyl) -pyridine-2-yl-amino] -propionic acid ethyl Aster methane sulfonate in its crystalline form ii, its containing pharmaceutical preparations, and its use in the preparation of appropriate pharmaceutical preparations for prevention after deep vein thrombosis and for the prevention of stroke and its preparation
WO2006082501A3 (en) Fast wet-massing method for the preparation of calcium-containing compositions
ITTV20050068A1 (it) Procedimento ed impianto per la fabbricazione di blocchi di conglomerato in materiale lapideo o ceramico.
HK1093746A1 (zh) 磷酸核苷作為治療病毒感染的藥物組合物的活性成份的應用，以及用於它們的生產的中間體
WO2011056775A3 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
CN105249333A (zh) 一种抗组织塌陷的冻干芒果块制备方法
WO2004102795A3 (en) Piezoelectric composites and methods for manufacturing same
JP5874179B2 (ja) 陶磁器板
NZ629598A (en) Stable bioactive substances and methods of making
WO2005049527A3 (en) Microcellular ceramic material, method for preparing it, and products obtained with the material and the method
WO2008035289A8 (en) Production of pyrotechnic delay composition
WO2008000453A3 (en) Process for preparing a solid dosage form
RU2588503C2 (ru) Способ изготовления высокотемпературной теплоизоляции
RU57667U1 (ru) Строительные изделия
CN107913500A (zh) 利用植物秸秆配制高尔夫球钉
JP2015227285A (ja) 陶磁器板の製造方法
RU2012131262A (ru) Способ изготовления вспененных строительных материалов
WO2005112882A3 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211024